Article
Novo Nordisk shares rise as Wegovy shows heart benefits beyond weight loss
Rating:
0.0
Views:
39
Likes:
1
Library:
1
Novo Nordisk shares rose 3% on Monday as the market reacted to data the drugmaker presented over the weekend showing that the heart protective benefits of its popular obesity drug Wegovy are not solely due to weight loss.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value